|Bid||0.1500 x 0|
|Ask||0.1550 x 0|
|Day's Range||0.1550 - 0.1550|
|52 Week Range||0.1000 - 0.2600|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Apr. 28, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
MedX Health Corp. ("MedX" or the "Company") (TSX-V: MDX) is pleased to announce the appointment of Sylvain Desjeans as Chief Revenue Officer. With more than 30 years of health-care industry experience, Mr. Desjeans is a seasoned leader who has successfully implemented and led large-scale strategic growth plans and global product licensing initiatives for international pharmaceutical and medical companies. He comes to MedX from tenures as Country Manager (Canada) for Aspen Pharmacare and senior leadership positions at Accucaps Industries Limited and Biovail Pharmaceuticals.
MedX Health Corp. ("MedX" or the "Company") (TSX-V: MDX) announced its results for the year ended December 31, 2020, which are also available on SEDAR (www.sedar.com).
MedX Health Corp. (TSXV: MDX) ("MedX" or the "Company"), a global leader in teledermatology, will present at the Planet MicroCap Showcase: VIRTUAL on Thursday, April 22nd at 12:00 PM EDT.